How much is the medical insurance reimbursement price of Jisandai (Bingtonsha)?

Epclusa (Epclusa) is an oral antiviral drug developed by Gilead Sciences for the treatment of chronic hepatitis C virus (HCV) infection of all genotypes. Its main ingredients are sofosbuvir (Sofosbuvir) and velpatasvir (Velpatasvir), which are nucleotide polymerase inhibitors and NS5A inhibitors respectively. The combination of the two can effectively block the replication and spread of hepatitis C virus.

Jisandai (Bingtonsha) is now on the market in China and has been included in the medical insurance catalog. Patients can buy it domestically at a price of about more than 3,000 yuan. For specific prices and medical insurance reimbursement details, please consult your local hospital or pharmacy. In comparison, the price of generic drugs produced in India and Bangladesh is relatively low, about a few hundred yuan, and their drug ingredients are basically the same as the domestic versions.

Jisandai (Bingtonsha) is indicated for the treatment of all six genotypes of hepatitis C, regardless of whether the patient has cirrhosis or not. For patients with decompensated cirrhosis, Bingtonsa is usually used in combination with ribavirin (Ribavirin) to improve the efficacy. One tablet per day, usually lasting 12 weeks, can enable the vast majority of patients to achieve sustained virological response (SVR12), that is, no virus is detectable 12 weeks after completion of treatment.

Clinical trials have shown that Jisandai (Bingtonsha) has a cure rate of more than 95% for HCV patients of various genotypes. Common side effects include headache, fatigue and nausea, which are usually mild. For patients with severe hepatic impairment, liver function should be closely monitored during treatment.

During the use of Gisanda (Bintongsha) , you should avoid taking proton pump inhibitors that may interfere with drug absorption. In addition, patients should have their viral load and liver function monitored regularly during treatment. Jisandai (Bingtonsha) is not suitable for pregnant and lactating women. Before starting treatment, you need to inform your doctor of all medications you are taking or potential health problems.